Articles tagged with Cancer Treatments
A study found that genetic variation of the CYP2D6 enzyme is associated with clinical outcomes for women treated with tamoxifen. Women with reduced or absent CYP2D6 function had higher breast cancer event rates and poorer survival rates compared to those with extensive metabolism.
Researchers investigated the effects of curcumin on head and neck squamous cell carcinoma growths in response to nicotine. Curcumin was found to block the nicotine from activating cancer-causing cells.
A combination of PET/CT tests expedited diagnosis of lung cancer in a fast-tracked setting, demonstrating high sensitivity and accuracy. Researchers evaluated 114 patients and made accurate diagnoses for 92%, with malignancy detected in 84%. This approach allows for timely treatment initiation without delays.
A Swiss study found that prostate cancer patients with lower incomes receive worse care and have a higher risk of dying from the disease. The research suggests that socioeconomic status plays a significant role in prostate cancer mortality, with poorer patients receiving less comprehensive treatment and more advanced stages at diagnosis.
Van Andel Institute researchers found the gene RhoB is crucial in the progression of Myelodysplastic Syndrome (MDS), a bone marrow disease affecting up to 15,000 people annually. The study's findings may lead to new treatments for late-stage MDS and its potential applications in leukemia and solid tumors.
A study by BUSM researchers suggests a connection between low testosterone levels and an increased risk of heart disease. The findings, published in the Journal of Andrology, support the idea that androgen replacement therapy could help reduce cardiovascular risk in hypogonadal men.
Hilde Cheroutre's groundbreaking proposal aims to pinpoint molecular events underlying autoimmunity susceptibility, enabling early detection and potentially preventing the disease. Her innovative approach could also lead to new therapies for those at high risk or already affected by autoimmunity.
Researchers discovered a genetic variation near the interferon gene IL28B associated with people's response to treatment. This finding could lead to the development of a diagnostic test and more effective treatments for hepatitis C, reducing adverse effects and improving outcomes.
Cancer experts are developing a tool to work out the percentage risk a woman has of developing cervical cancer. The tool uses cervical precancer, defined as histological cervical intraepithelial neoplasia grade 3 (CIN3) or more severe, as a surrogate for cervical cancer.
A large trial found that hormone replacement therapy (HRT) increases the risk of death from lung cancer, especially non-small-cell lung cancer. Women taking HRT were 71% more likely to die from lung cancer than those on placebo, with higher risks also seen in current and long-term past smokers.
Chronic pain affects 80% of those living with it, and up to 10% gain access to effective treatments; a national strategy is long overdue to address the issue's significant economic and personal burden.
Research on endothelin-1 (ET-1) reveals its role in promoting fibrosis in pancreatic stellate cells. ET-1 stimulates cell activation, leading to inflammation and fibrosis. Inhibition of ET-1 may offer a novel approach to treating chronic pancreatitis and pancreatic cancer.
Treatments like insulin and metformin do not reduce inflammatory biomarkers, such as hsCRP, despite improving glucose control. No consistent association was found between glucose reduction and improvement in inflammatory status.
A study found improved survival rates for men with localized prostate cancer diagnosed between 1992 and 2002 compared to earlier eras. The 10-year prostate cancer-specific mortality rate was 8.3% for well-differentiated tumors, lower than previous reports.
A recent meta-analysis published in Cancer found that depression is associated with a higher risk of death in cancer patients, with death rates up to 25% higher for those experiencing depressive symptoms. The study highlights the need for systematic screening and treatment of psychological distress in cancer patients.
Researchers have developed a new method to detect early signs of oxidative stress in cancer, which can be used to tailor treatments. The method identifies sulfenic acid in proteins, a marker of oxidative stress, and reveals that different individuals and tumor types have unique redox profiles.
Scientists have developed nanoparticles that can target and destroy glioblastoma multiforme (GBM) brain cancer cells using light-sensitive titanium dioxide material. The 'nanobio hybrids' killed up to 80% of brain cancer cells after exposure to focused white light, making them a promising part of brain cancer therapy.
Researchers induced pathological damage to a normal pancreas with an immune adjuvant and found that it triggered a strong anti-self response, which suppressed autoimmunity. The study highlights the complexity of immune responses in different organs and may lead to new therapeutic approaches for cancer treatment
The DFG has established five new Clinical Research Units to study highly topical medical issues such as bowel cancer metastases and hormone-related obesity. The units aim to develop individual forms of treatment for conditions like glomerulonephritis and improve diagnostic strategies,
Researchers at UM Medical Center have identified haptoglobin 2 precursor as the molecular link to zonulin, a protein associated with inflammatory disorders. This discovery could lead to new treatments and diagnostic tools for celiac disease and other autoimmune conditions.
A new probe identifies over 190 proteins that undergo oxidation due to ROS, offering insights into disease processes and potential targets for treatments. The discovery may lead to strategies for fighting diseases involving excessive oxidation reactions.
A pooled analysis of six clinical trials found that pretreatment quality of life can predict overall survival in patients with advanced stage NSCLC. Patients with low self-assessed quality of life have twice the risk of death as those with high scores.
Researchers at Northwestern University developed a novel gene delivery technology using nanodiamonds, achieving 70 times greater delivery efficiency than conventional methods. The surface-modified particles successfully delivered DNA into mammalian cells while preserving biocompatibility.
Researchers at Mayo Clinic have found that early stage cancers of the esophagus can be treated effectively with less-invasive, organ-sparing endoscopic therapy. This approach was compared to traditional surgical removal of the esophagus and showed comparable overall mortality rates.
Researchers identified Hexokinase 2 as a key player in glucose metabolism and cell survival for breast cancer patients with brain metastases. Patients with high levels of Hexokinase 2 expression in their brain metastasis had significantly lower median survival rates compared to those with lower expression.
Researchers at Fox Chase Cancer Center found that long travel distances to high volume centers pose a barrier to optimal cancer care for some patients. The study showed that increased travel distances were more common among patients with less common cancers, such as esophageal and pancreatic cancer.
Studies suggest that raising hemoglobin levels with erythropoietin can improve exercise tolerance in heart failure patients. However, a large-scale trial is needed to determine if higher Hb targets are associated with adverse cardiovascular events.
Research reveals distinct patterns of intestinal response to arterial, venous, or total mesenteric ischemia/reperfusion, influencing the severity of injury. This knowledge could lead to targeted therapies for specific conditions, including venous occlusion, arterial ischemia, and transplant procedures.
A recent study published in the Journal of Thoracic Oncology found that tumor size and level of visceral pleura invasion significantly impact the survival of non-small cell lung cancer (NSCLC) patients. Researchers analyzed data from over 9,700 surgical resection cases and divided patients into nine groups based on tumor size and VPI.
A recent study led by Keith Lindor found that patients with primary sclerosing cholangitis (PSC) who received high-dose ursodeoxycholic acid experienced poorer clinical results compared to those receiving a placebo. The therapy was associated with an increased risk of death, transplantation, and liver damage.
Researchers identified a genetic marker that predicts response to hepatitis C treatments, revealing a single-letter DNA change near the IL28B gene. This discovery explains why African-Americans and East Asians respond differently to treatment, highlighting individual genetic makeup as a key determinant of response.
Researchers have discovered how the DISC complex triggers cell death or survival by switching key molecules' activity levels. Stopping the DISC from functioning properly prevents efficient cell death, resulting in disease conditions like ALPS.
A new experimental treatment, GIFT15, has been shown to completely reverse multiple sclerosis in mice by suppressing the immune response. The treatment, which combines two proteins, may also be effective against other autoimmune disorders like Crohn's disease and lupus.
A new study published in The Lancet found that adding a TNF antagonist like infliximab to methotrexate treatment improves symptoms for patients with early rheumatoid arthritis who have not responded well to methotrexate alone. This approach can prevent overtreatment and reduce side effects and costs.
A two-year study found that three treatment combinations for clearing the most common form of hepatitis C virus work equally well, with about 40% clearance rates. Researchers also noted that women achieved higher rates of virus clearance with the standard dose of peginterferon alfa-2b.
New DNA and RNA aptamers have shown promise as treatments for various diseases, including macular degeneration and cancer. Their ease of production, stability, and chemical modifications enhance their drug-like properties.
Researchers found that intermittent calorie restriction provided greater protection from mammary tumor development, even with a lower degree of calorie restriction. The study suggests that altering hormone levels, such as insulin and IGF-1, may play a key role in cancer prevention.
A groundbreaking clinical trial has shown that exercise can significantly improve symptoms of fatigue and depression, increase cardiovascular endurance, and maintain quality of life for adult leukemia patients undergoing treatment. The study demonstrated a substantial reduction in total fatigue and depression scores, as well as improve...
Studies reveal that hepatitis C virus carriers have a significant increase in mortality, with liver-related deaths being the leading cause. The research found that monitoring HCV load and ALT levels may be crucial for identifying high-risk individuals, particularly older carriers who are less responsive to treatment.
A study found that S-adenosylmethionine (SAMe) prevents the formation of hepatocellular carcinoma (HCC) in rats, with a 1cm tumor reduced in size after treatment. However, high doses were not sufficient to treat established HCC cases, as the liver compensates for SAMe accumulation by metabolizing it.
The Peninsula College of Medicine and Dentistry has received a grant to study the role of brain tumors in deafness and develop non-invasive therapies. The research aims to identify how tumors grow and cause hearing damage, and test drug-based treatments.
A recent study published in Cancer found that men with early stages of prostate cancer who delay radical treatment have acceptable levels of anxiety and distress. The study's results suggest that living with untreated cancer is not upsetting for many patients, but certain mental and physical factors can increase distress.
Developed a compact gamma camera called ProxiScan to localize prostate cancer tissue with high resolution. The camera system enables early diagnosis and treatment of potentially deadly disease.
UT Southwestern Medical Center researchers have received a $2 million grant to study lung cancer in nonsmokers. They will use a coordinated approach to discover biomarkers and develop a test to detect early-stage lung cancer.
The American Society of Hematology is honoring six scientists for their significant contributions to hematologic diseases, including the diagnosis and treatment of lymphomas and leukemia. The awards recognize pioneering research achievements and outstanding leadership in advancing the field of hematology.
A Purdue University scientist has discovered a key process in cell growth that can lead to the formation of tumors. The research found that an overabundance of the polo-like kinase 1 molecule during cell growth, as well as a shortage of the p53 molecule, will lead to tumor formation.
The American Society of Plastic Surgeons reports nearly 70% of eligible women lack information on breast reconstruction procedures. To address this issue, ASPS is launching an awareness campaign to educate and empower patients to make informed decisions about their care.
Scientists at QIMR have discovered two genes that significantly increase the risk of developing melanoma in people with multiple moles. This groundbreaking research will help develop new screening techniques and potentially lead to new therapies for this deadly skin cancer.
Researchers at the University of Oklahoma Health Sciences Center discovered a natural compound that restores balance in the eye to stop diabetic retinopathy, a disease affecting five million Americans. The treatment prevents leakage, blocks inflammation, and stops unwanted blood vessel growth.
Researchers at Cedars-Sinai have developed a novel gene therapy that uses immune cells to target glioblastoma multiforme. A specific biomarker, HMGB1, has been identified as an effective tool to monitor tumor response to this treatment.
Scientists have found that mechano growth factor (MGF) stimulates muscle development by activating stem cells in response to exercise. MGF has great potential as a therapeutic treatment for age-related muscle loss and diseases such as muscular dystrophy, ALS, and cancer.
A new three-way measurement method has been developed to predict disease metastasis in prostate cancer, combining PSA doubling time, Gleason score, and interval between surgery and detectable PSA levels. This improved prediction method may help determine which patients benefit from additional therapy after surgery.
Biocatalogue.org provides a centralized registry of curated life science Web Services, enabling researchers to discover and use biological tools for treatments of H1N1 flu and cancer. The service is expected to significantly accelerate research in the medical, agronomical, and pharmaceutical fields.
A study published in the Journal of Thoracic Oncology found a significant difference in the quality and type of lung cancer information available online in the US and Japan. The US websites were more likely to discuss standard treatment methods and had stricter ethical policies.
The University of Illinois Chicago is leading a five-year study to increase demand for evidence-based, Internet-based smoking cessation treatment among young adults. The project aims to develop interactive, Internet-based ads and evaluate their effectiveness in motivating young smokers to use the stop smoking program www.BecomeAnEx.org.
Researchers found that ultra-fast freezing of ovarian tissue can achieve the same success rate as fresh tissue in transplants, with a viability rate of 91.9% compared to 88.9%. The cortical grafting technique allows for simpler procedure with equally successful results, enabling women to have children later in life.
Research reveals Alisol B acetate inhibits proliferation of gastric cancer cells and induces apoptosis through mitochondrial and PI3K/Akt signaling pathways. This could lead to the development of a new anticancer agent for treating gastric cancer, one of the most common cancers worldwide.
The UK has launched a £41 million initiative to develop innovative medical solutions for osteoarthritis, aging populations, and imaging technologies. Four new Centres of Excellence will integrate clinicians, biomedical scientists, and engineers to create high-tech treatments.
The AGA Foundation has awarded a $150,000 grant to Dr. Michael Choi for his research on carcinoid tumors, a type of neuroendocrine cancer. This funding will support the development of novel therapeutic approaches to improve treatment outcomes for patients with these rare and often slow-growing cancers.
A recent study suggests that weight-loss surgery could be associated with reduced cancer risk in obese women, with a 42% decrease in first-time cancers over 10 years. However, the surgery had no effect on cancer incidence in men. The findings indicate that bariatric surgery may have broader benefits for women's cancer prevention.